Pharma Summit on Business & Compliance Issues in Managed Markets

June 8-9, 2016 | Washington, D.C.

Keynote Presenters

Susan Asante-Abedi, MS

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
Senior Principal
IMS Consulting Group

Timothy Ayers, JD, MPH

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
VP and Chief Compliance Officer; Former VP, Chief Compliance Officer
Horizon Pharma plc

Blake Bolinger, Esq.

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
Director, US Pharmaceuticals, Compliance and Ethics
Bristol-Myers Squibb

Patrick H. Conway, MD, MSc

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
Deputy Administrator for Innovation and Quality
Center for Medicare and Medicaid Innovation

Meenakshi Datta, Esq.

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
Partner
Sidley Austin LLP

Susan Dentzer

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
President and CEO
The Network for Excellence in Health Innovation

Michelle Drozd, ScM

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
Deputy VP, Policy and Research
Pharmaceutical Research and Manufacturers of America (PhRMA)

Anthony Greco, MBA

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
Director
PwC

Seth Lundy, Esq.

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
Partner
King and Spalding

Samuel R. Nussbaum, MD

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
Chair; Former Executive VP and CMO
Anthem

Alonzo Weems, JD

Pharma Summit on Business & Compliance Issues in Managed Markets Speaker
VP and Deputy General Counsel
Lilly USA, LLC

Silver Grantors

Bronze Grantors